Blog
RSS FeedPosted by Michael Wonder on 01 Oct 2020
Proposal to decline inactive funding applications
1 October 2020 - To help make the decision-making process clearer, PHARMAC is seeking feedback on a proposal for the ...
Posted by Michael Wonder on 01 Oct 2020
New procedures for CADTH drug reimbursement reviews
30 September 2020 - CADTH initiated stakeholder consultations in June 2020 on proposals to align the procedure for its drug ...
Posted by Michael Wonder on 01 Oct 2020
US FDA grants rare paediatric disease designation to ATL1102 for the treatment of DMD
30 September 2020 - Priority review voucher may be utilised to expedite marketing authorisation review by FDA. ...
Posted by Michael Wonder on 01 Oct 2020
Pharmacist prescribers able to prescribe special authority medicines
1 October 2020 - Some medicines are only funded under certain conditions to ensure access to medicines is available for ...
Posted by Michael Wonder on 30 Sep 2020
The FDA and the importance of trust
30 September 2020 - As SARS-CoV-2 emerged, the global scientific community first studied the virus at the bench, then took what ...
Posted by Michael Wonder on 30 Sep 2020
Janssen submits new drug application to U.S. FDA for Uptravi (selexipag) injection for intravenous use to treat pulmonary arterial hypertension
30 September 2020 - Janssen today announced the submission of a new drug application to the U.S. FDA for Uptravi ...
Posted by Michael Wonder on 30 Sep 2020
Schedule of Pharmaceutical Benefits - 1 October 2020 update
1 October 2020 - The October 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Sep 2020
Simponi Aria (golimumab) approved by the U.S. FDA for active polyarticular juvenile idiopathic arthritis and extension of its active psoriatic arthritis indication in patients 2 years of age and older
30 September 2020 - Phase 3 GO-VIVA clinical trial adds to the growing body of evidence for Simponi Aria. ...
Posted by Michael Wonder on 30 Sep 2020
House panel says drug makers inflated prices to boost profits and reap bonuses
30 September 2020 - The Democrat-led reports come just weeks before Election Day, and amid efforts by President Donald Trump to ...
Posted by Michael Wonder on 30 Sep 2020
New Zealand Pharmaceutical Schedule - 1 October 2020
1 October 2020 - The October 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Sep 2020
Internationally respected medical specialist slams PHARMAC, urges PM to investigate
30 September 2020 - In a blistering open letter to Prime Minister Ardern, world renowned expert in Crohn’s disease and ...
Posted by Michael Wonder on 30 Sep 2020
Patrick admits no medical shortages from wharf dispute - yet
30 September 2020 - The head of Patrick Terminals has admitted the industrial dispute roiling Australia's ports has not led ...
Posted by Michael Wonder on 30 Sep 2020
New dual therapy PBS restrictions for pulmonary arterial hypertension medicines
30 September 2020 - Access to medicines for pulmonary arterial hypertension has improved as an outcome of the post-market review of ...
Posted by Michael Wonder on 30 Sep 2020
Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before.
29 September 2020 - Not only has he lowered drug prices, President Trump claimed in the first 15 minutes of ...
Posted by Michael Wonder on 30 Sep 2020
Saxenda is not included in the high-cost protection
29 September 2020 - Liraglutide (Saxenda), which is intended for weight control in adult patients with obesity or are overweight, ...